The incidence of pulmonary arterial hypertension (PAH) has increased worldwide over the past three decades, although death rates and disability-adjusted life year (DALY) rates related to the ...

Roche’s hopes of getting astegolimab to regulators this year took a hit after the anti-ST2 antibody failed to reduce flare-ups in a phase 3 study.

Topline data were announced from two phase 3 trials evaluating astegolimab in patients with moderate to very severe COPD.

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, marking the second biologic approved as an add-on maintenance treatment ...

Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its treatment of pulmonary arterial hypertension.

Sly Stone died after a prolonged battle with COPD, a lung condition that can be debilitating. Here's what doctors want you to know about it.

Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the Regeneron-partnered drug ...

The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD).

Novel rat model paves the way to advance COPD-associated cor pulmonale research Date: May 2, 2025 Source: Elsevier Summary: Researchers have developed a novel rat model that closely replicates the ...

ABGs, arterial blood gases; CONSORT, Consolidated Standards of Reporting Trials; COPD, chronic obstructive pulmonary disease; ITT, intention to treat; NIV, non-invasive ventilation; PtCO 2, ...

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The eff ...

A person can get a COPD inhaler through Medicare Part D or a Medicare Advantage (Part C) plan with prescription coverage.